LTR Pharma Limited (ASX:LTP)
Australia · Delayed Price · Currency is AUD 0.4700
-0.0100 (-2.08%)
Oct 1, 2026, 4:10 PM AEST
LTR Pharma Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 0.72 | 1.51 | 0.05 | - | - |
Other Revenue | - | - | - | - | 0.01 |
| 0.72 | 1.51 | 0.05 | - | 0.01 | |
Revenue Growth | -52.01% | 2978.25% | - | - | - |
Cost of Revenue | 6.69 | 2.79 | 3.51 | - | - |
Gross Profit | -5.97 | -1.28 | -3.46 | - | 0.01 |
Selling, General & Admin | 4.65 | 3.63 | 2.01 | 0.59 | 0.68 |
Research & Development | - | - | - | 0.82 | 0.35 |
Other Operating Expenses | 0.29 | 0.4 | 0.17 | 0.03 | - |
Operating Expenses | 8.02 | 4.83 | 3.48 | 1.44 | 1.03 |
Operating Income | -13.99 | -6.11 | -6.94 | -1.44 | -1.02 |
Interest Expense | -0 | -0 | -0 | -0 | -0 |
Interest & Investment Income | 0.9 | 0.6 | 0 | 0 | 0 |
Earnings From Equity Investments | -1.04 | -0.06 | - | - | - |
Currency Exchange Gain (Loss) | -0.03 | -0.02 | -0.01 | -0.02 | -0.01 |
Pretax Income | -14.16 | -5.59 | -6.95 | -1.45 | -1.03 |
Net Income | -14.16 | -5.59 | -6.95 | -1.45 | -1.03 |
Net Income to Common | -14.16 | -5.59 | -6.95 | -1.45 | -1.03 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 182 | 167 | 139 | 260 | - |
Shares Outstanding (Diluted) | 182 | 167 | 139 | 260 | - |
Shares Change | 8.54% | 19.96% | -46.34% | - | - |
EPS (Basic) | -0.08 | -0.03 | -0.05 | -0.01 | - |
EPS (Diluted) | -0.08 | -0.03 | -0.05 | -0.01 | - |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -10.85 | -4.45 | -5.09 | -1.54 | -0.57 |
Free Cash Flow Per Share | -0.06 | -0.03 | -0.04 | -0.01 | - |
Gross Margin | - | -84.75% | - | - | 100.00% |
Operating Margin | -1932.77% | -404.86% | -14162.27% | - | -11195.03% |
Profit Margin | -1956.57% | -370.83% | -14192.25% | - | -11314.40% |
Free Cash Flow Margin | -1498.07% | -294.96% | -10396.58% | - | -6258.86% |
EBITDA | -13.99 | -6.1 | -6.94 | - | - |
D&A For EBITDA | 0.01 | 0 | 0 | - | - |
EBIT | -13.99 | -6.11 | -6.94 | -1.44 | -1.02 |
Revenue as Reported | 1.62 | 2.1 | 0.05 | - | - |
Advertising Expenses | 0.86 | 0.75 | 0.36 | - | 0 |